Techniques for Optimizing Surgical Scars, Part 3: Erythema, Hyperpigmentation, and Hypopigmentation.

Abstract

Surgical management of benign or malignant cutaneous tumors may result in noticeable scars that are of great concern to patients, regardless of sex, age, or ethnicity. Techniques to optimize surgical scars are discussed in this three-part review. Part 3 focuses on scar revision for erythema, hyperpigmentation, and hypopigmentation. Scar revision options for erythematous scars include moist exposed burn ointment (MEBO), onion extract, silicone, methyl aminolevulinate-photodynamic therapy (MAL-PDT), pulsed dye laser, intense pulsed light (IPL), and nonablative fractional lasers. Hyperpigmented scars may be treated with tyrosinase inhibitors, IPL, and nonablative fractional lasers. Hypopigmented scars may be treated with needle dermabrasion, medical tattoos, autologous cell transplantation, prostaglandin analogues, retinoids, calcineurin inhibitors, excimer laser, and nonablative fractional lasers.

• Authors: Kathryn Potter, Sailesh Konda, Vicky Zhen Ren, Apphia Lihan Wang, Aditya Srinivasan, Suneel Chilukuri
• Journal: Skinmed (Skinmed) 2018 Vol. 16 Issue 2 Pg. 113-117 ISSN: 1540-9740 [Print] United States
• PMID: 29911529 (Publication Type: Journal Article, Review)

Chemical References

• Dermatologic Agents
• Retinoids

Topics

• Cicatrix (prevention & control)
• Dermabrasion (methods)
• Dermatologic Agents (therapeutic use)
• Dermatologic Surgical Procedures (adverse effects, methods)
• Erythema (etiology, therapy)
• Esthetics
• Female
• Humans
• Hyperpigmentation (etiology, therapy)
• Hypopigmentation (etiology, therapy)
• Low-Level Light Therapy (methods)
• Male
• Retinoids (therapeutic use)
• Skin Neoplasms (pathology, surgery)
• Treatment Outcome